Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7VL7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,660
Award facts
- Contract value 100% obligated
- $63,659.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,659.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. The contract was executed on January 28, 2026, with an ultimate completion date of January 29, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 31, 2031.
Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps. The delivery of this specialized pharmaceutical product supports the military healthcare supply chain and the Defense Health Agency's mission to provide medical commodities to military treatment facilities and service members. AmerisourceBergen's role as a primary pharmaceutical vendor demonstrates its capability to supply brand-name specialty medications alongside generic drugs and vaccines across multiple therapeutic domains to federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F7VL7?
SPE2DR26F7VL7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F7VL7 worth?
The government has obligated $63,660 on SPE2DR26F7VL7.
Is contract SPE2DR26F7VL7 an order under another contract?
Yes. SPE2DR26F7VL7 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VL7 competed?
The extent of competition for SPE2DR26F7VL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award